Zoetis Inc.
A maker of medicines, vaccines, and diagnostics for animals, Zoetis sells well-known products like the dog itch-relief drugs Apoquel and Cytopoint and Simparica parasite preventives to veterinarians worldwide. Born in the 1950s as the animal health arm of Pfizer, it became a fully independent company in 2013. Its name comes from the Greek word "zoe," meaning life—a fitting nod to its mission of keeping animals healthy.
Bought 1.54M · Sold 18.39M
Granted 1.87M · Sold 1.34M
Granted 547.1K · Sold 305.2K
Granted 243.9K · Sold 148.3K
Granted 276.7K · Bought 1.0K · Sold 188.0K
Granted 25.8K · Bought 12.0K
Granted 285.0K · Bought 2.5K · Sold 205.4K
Granted 30.6K · Bought 4.5K
Granted 132.5K · Bought 500 · Sold 73.5K
Granted 25.9K · Bought 2.0K
Granted 28.8K · Sold 26.6K
Granted 39.9K
Granted 14.4K · Bought 11.7K
Granted 37.9K
Granted 25.8K · Bought 3.0K · Sold 4.5K
Granted 264.5K · Bought 2.0K · Sold 205.5K
Granted 152.8K · Sold 115.3K
Granted 35.9K · Bought 7.6K
Granted 25.7K · Sold 12.9K
Granted 15.7K · Sold 1.1K
Granted 110.7K · Sold 85.3K
Granted 11.4K · Sold 8.2K
Granted 7.5K · Bought 2.0K
Granted 3.1K
Granted 10.3K
Granted 7.0K
Granted 12.9K · Sold 5.8K
Bought 5.0K
Bought 5.0K
Bought 5.0K
Bought 5.0K
Granted 3.1K · Bought 2.0K
Granted 4.6K
Granted 5.8K
Granted 3.7K
Granted 3.8K · Bought 320
Granted 3.1K
Granted 3.7K
Granted 2.2K
Granted 3.8K
Granted 14.4K · Bought 17 · Sold 17
Granted 2.8K
Granted 1.6K
Granted 454
Granted 1.5K
Granted 895
Sold 99.02M
Granted 3.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Ackman William A +2 co-filersDirector · 3 transactions | — | 66.80Mas of May 2016 | — | 1.54M | 18.39M |
| Alaix Juan RamonDirector · 50 transactions | — | 215.1Kas of May 2021 | 1.87M | — | 1.34M |
| Peck Kristin CChief Executive Officer, Director · 127 transactions | — | 105.9K | 547.1K | — | 305.2K |
| David GlennExecutive Vice President · 48 transactions | — | 52.5Kas of Feb 2022 | 243.9K | — | 148.3K |
| Knupp Catherine A.Executive Vice President · 47 transactions | — | 43.6Kas of Nov 2021 | 276.7K | 1.0K | 188.0K |
| McCallister Michael BDirector · 31 transactions | — | 39.3K | 25.8K | 12.0K | — |
| Chen Heidi C.Executive Vice President · 97 transactions | — | 32.4Kas of Feb 2024 | 285.0K | 2.5K | 205.4K |
| Steere William C JrDirector · 11 transactions | — | 29.4Kas of May 2021 | 30.6K | 4.5K | — |
| Lewis Clinton A. Jr.Executive Vice President · 50 transactions | — | 27.9Kas of Dec 2019 | 132.5K | 500 | 73.5K |
| Bisaro PaulDirector · 12 transactions | — | 27.9K | 25.9K | 2.0K | — |
| Fenton AndrewExecutive Vice President · 17 transactions | — | 23.1Kas of Dec 2019 | 28.8K | — | 26.6K |
| Joseph WettenyChief Financial Officer · 18 transactions | — | 22.8K | 39.9K | — | — |
| Damelio Frank ADirector · 12 transactions | — | 21.5K | 14.4K | 11.7K | — |
| Parent Louise MDirector · 26 transactions | — | 18.2K | 37.9K | — | — |
| Norden GregoryDirector · 34 transactions | — | 18.2K | 25.8K | 3.0K | 4.5K |
| Lagano RoxanneExecutive Vice President · 129 transactions | — | 16.5K | 264.5K | 2.0K | 205.5K |
| Trawicki RomanExecutive Vice President · 55 transactions | — | 14.2Kas of Mar 2022 | 152.8K | — | 115.3K |
| Scully Robert WDirector · 19 transactions | — | 13.1Kas of May 2025 | 35.9K | 7.6K | — |
| Reed Willie MDirector · 18 transactions | — | 12.9K | 25.7K | — | 12.9K |
| Rhodes LindaDirector · 15 transactions | — | 11.7Kas of May 2024 | 15.7K | — | 1.1K |
| Bernal AlejandroExecutive Vice President · 24 transactions | — | 11.4Kas of Feb 2018 | 110.7K | — | 85.3K |
| Kelly Robert EdwardExecutive Vice President · 20 transactions | — | 9.6Kas of May 2021 | 11.4K | — | 8.2K |
| Beaty Sandra J.Executive Vice President · 10 transactions | — | 6.7Kas of Feb 2015 | 7.5K | 2.0K | — |
| Driscoll RimmaExecutive Vice President · 22 transactions | — | 5.9K | 3.1K | — | — |
| Mamilli WafaaExecutive Vice President · 10 transactions | — | 5.7Kas of Feb 2024 | 10.3K | — | — |
| Leatherberry Antoinette ReneeDirector · 10 transactions | — | 5.3K | 7.0K | — | — |
| Polzer Robert JExecutive Vice President · 27 transactions | — | 5.2Kas of Feb 2025 | 12.9K | — | 5.8K |
| Germano Geno JDirector · 1 transaction | — | 5.0Kas of Feb 2013 | — | 5.0K | — |
| Giordano Douglas E.Director · 1 transaction | — | 5.0Kas of Feb 2013 | — | 5.0K | — |
| Hill Charles HDirector · 1 transaction | — | 5.0Kas of Feb 2013 | — | 5.0K | — |
| Schulman Amy WDirector · 1 transaction | — | 5.0Kas of Feb 2013 | — | 5.0K | — |
| Lee Joyce J.Executive Vice President · 9 transactions | — | 4.8Kas of Feb 2015 | 3.1K | 2.0K | — |
| Brannan JamieExecutive Vice President · 22 transactions | — | 4.3K | 4.6K | — | — |
| Broadhurst VanessaDirector · 8 transactions | — | 3.9K | 5.8K | — | — |
| Passov Richard A.EVP, Chief Financial Officer · 5 transactions | — | 3.7Kas of Feb 2014 | 3.7K | — | — |
| Weiskopf StefanExecutive Vice President · 10 transactions | — | 3.7Kas of Feb 2015 | 3.8K | 320 | — |
| Hattersley GavinDirector · 3 transactions | — | 3.4K | 3.1K | — | — |
| Sarbaugh KeithExecutive Vice President · 10 transactions | — | 3.3K | 3.7K | — | — |
| McFarland James MichaelExecutive Vice President · 8 transactions | — | 2.3Kas of Feb 2021 | 2.2K | — | — |
| Ashton NicholasExecutive Vice President · 20 transactions | — | 2.2K | 3.8K | — | — |
| Sanjay KhoslaDirector · 13 transactions | — | 1.9Kas of Feb 2021 | 14.4K | 17 | 17 |
| Ferran Astorga JeannetteExecutive Vice President · 20 transactions | — | 1.9K | 2.8K | — | — |
| Stetter MarkDirector · 1 transaction | — | 1.6K | 1.6K | — | — |
| Esch KevinExecutive Vice President · 8 transactions | — | 1.1K | 454 | — | — |
| Fuller JulieExecutive Vice President · 4 transactions | — | 1.1K | 1.5K | — | — |
| Banque Soria EsterExecutive Vice President · 2 transactions | — | 895as of Jul 2024 | 895 | — | — |
| Pfizer Inc10% owner · 4 transactions | — | 0as of Jun 2013 | — | — | 99.02M |
| Nayak Abhay UExecutive Vice President · 6 transactions | — | 0 | 3.1K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -118.52M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.